A comprehensive evaluation of the overall impact of aluminum on human health is overdue

A decade since the launch of the vaccine a book questions the claim it prevents cancer,’ wrote Carolyn Moynihan as she began her review of my book Gardasil: Fast-Tracked and Flawed published in August in MercatorNet. Her review was fair with her concluding paragraph:
Lobato concludes her book with an appeal to the media to do their job and give the public the fuller story about the HPV vaccine. You may not agree with her version of the story at all points, but she has shown Big Media some of the things they could be airing in the interests of informed debate.
A month later MercatorNet has published another piece presenting ‘expert’ evidence given by Professor Silvia Carlos an expert on infectious diseases in the Department of Preventive Medicine and Public Health at the University of Navarre, Spain. One of the issues that they discuss with Professor Silvia Carlos concerns the safety of aluminium in the HPV vaccine. It is vital that we understand this issue as Gardasil contains 225 micrograms of amorphous aluminum hydroxyphosphate sulfate per dose. The purpose and mechanism of the aluminium as an adjuvent is explained by Exley, C., Siesjö, P. & Eriksson as owing to the homogeneity and generally weak immunogenicity of recombinant antigens, the inclusion of adjuvants is often necessary for the induction of robust immune responses and effective immunisation. In other words the human papilloma virus-like particles made by DNA recombination technology are not strong enough to bring about an immune response so aluminium which enhances the body’s immune response is added.
Silvia Carlos claims that the amount of aluminium in the vaccines is low and quotes the CDC, Centres for Disease Control and Prevention which says that aluminium has been safely used in vaccines for over 70 years.
However Canadian researchers Lucija Tomljenovic and Christopher Shaw state in their paper Aluminium Adjuvants: Are they safe?  
Despite almost 90 years of widespread use of aluminum adjuvants, medical science’s understanding about their mechanisms of action is still remarkably poor. They state that:

Aluminum is an experimentally demonstrated neurotoxin. Experimental research clearly shows that aluminium adjuvants have a potential to induce serious immunological disorders in humans. In addition: the use of adjuvants in human vaccinations has been linked to adverse effects often classified under Autoimmune (or autoinflammatory) syndrome induced by adjuvants . Combined with the relatively low cost of hydrated colloidal aluminium salts and their ease of inclusion as effective adjuvants within clinically approved vaccine formulations, the continued use of ABA (aluminium based adjuvants) in human vaccinations is likely to continue. Aluminum adjuvants are also used in vaccines such as hepatitis A, hepatitis B, diphtheria-tetanus-containing vaccines, and Haemophilus influenzae type b and pneumococcal vaccines.

Canadian researchers Tomljenovic and Shaw state that unlike dietary aluminium which usually is rapidly cleared from the body, aluminium that is used in vaccines such as Gardasil ‘is designed to provide a long-lasting cellular exposure’. They explain that while the aluminium that is contained in vaccine facilitates an immune response against antigens it can make its way into the central nervous system. ‘It is not really a matter of much debate that aluminium in various forms can be neurotoxic.’

The authors of a study called Vaccines, adjuvants and autoimmunity have found that Vaccines and autoimmunity are linked fields. They report that: Vaccines are able to elicit the immune system towards an autoimmune reaction. It is vital that we understand the part that vaccines such as Gardasil play in the development of  autoimmune diseases for they are increasing all over the globe and currently affect one in five Americans. In the study the immunologists have reviewed cases of ‘vaccine-induced immunity’ explaining the process as Autoimmune Syndrome Induced by Adjuvants. Adjuvants are added to vaccines in order to stimulate the immune system to produce antibodies but in some people they cause immune reactions and symptoms that manifest as autoimmune disease. The latest HPV vaccine Gardasil 9 contains 500 micrograms of (AAHS) which is given as two or three shots.

The safety of our teenagers is at stake. They are being injected all over the world with Gardasil which has 225 micrograms per dose and in Australia next year will be given Gardasil 9 containing 500 micrograms per dose. Tomljenovic and Shaw call for a comprehensive evaluation of the overall impact of aluminum on human health which they stress is overdue. In the meantime the HPV vaccination programs should be ceased. There is zero scientific evidence that HPV vaccines have been proven to prevent a single case of cervical cancer in any country (Dr Sin Hang Lee).

 

 

 

Advertisements
Leave a comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: